Markets:

Overview

News

Currencies

International

Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

190.69 +0.84 (+0.44%)

Streaming Delayed Price Updated: 12:02 PM EDT, Jun 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - CRL

May 27, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Law Enforcement Lawsuit

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, and Charles River and Encourages Investors to Contact the Firm

May 24, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Charles River Laboratories International, Inc. (CRL)

May 24, 2023

From Law Offices of Howard G. Smith

Via Business Wire

Charles River: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

Will Chart Analysts Notice Bad Omen on Charles River's Chart ↗

April 13, 2023

Via Benzinga

Analyst Ratings for Charles River ↗

March 28, 2023

Via Benzinga

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Charles River Laboratories International, Inc. (CRL) Investors

May 23, 2023

From Kirby McInerney LLP

Via Business Wire

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Charles River Laboratories International, Inc. (CRL)

May 23, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Charles River Laboratories International, Inc. (CRL) Investors

May 23, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm

May 23, 2023

From The Schall Law Firm

Via Business Wire

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Charles River Laboratories International, Inc.

May 23, 2023

From Bernstein Liebhard LLP

Via GlobeNewswire

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Charles River Laboratories International, Inc. (CRL)

May 23, 2023

From Robbins LLP

Via Business Wire

CHARLES RIVER LABORATORIES SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against Charles River Laboratories International, Inc. - CRL

May 22, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm

May 22, 2023

From The Schall Law Firm

Via Business Wire

CRL EQUITY ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CRL

May 22, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Charles River Laboratories International, Inc. (CRL) Investors

May 22, 2023

From Law Offices of Howard G. Smith

Via Business Wire

CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Charles River Laboratories International, Inc. and Encourages Investors to Contact the Firm

May 21, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

CRL CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Charles River Laboratories International, Inc.

May 21, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

CRL CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Charles River Laboratories International, Inc.

May 19, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

3 DNA Stocks to Buy for the Synthetic Biology Revolution ↗

May 14, 2023

Synthetic biology is a growing industry. The big winners will be DNA stocks that are able to sell to everyone, not just a small niche.

Via InvestorPlace

Charles River Laboratories Announces First-Quarter 2023 Results

May 11, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID

May 01, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

3 Healthcare Stocks With Huge Growth Potential ↗

April 24, 2023

It's been a tough time for the tech industry. So consider these healthcare growth stocks to buy now instead.

Via InvestorPlace

Bragar Eagel & Squire, P.C. Is Investigating Fox, Charles River, Provident, and Sarepta and Encourages Investors to Contact the Firm

April 17, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Charles River Laboratories Schedules First-Quarter 2023 Earnings Release and Conference Call

April 11, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Showcases End-to-End Oncology Capabilities at AACR 2023

April 10, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Fox, FTX, RH, and Charles River and Encourages Investors to Contact the Firm

March 22, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL

March 17, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Law Enforcement Supply Chain

Charles River Laboratories International, Inc. (NYSE:CRL) Investor Alert: Investigation over Possible Violations of Securities Laws ↗

March 13, 2023

San Diego, CA -- (SBWIRE) -- 03/13/2023 -- An investigation was announced for investors of Charles River Laboratories International, Inc. (NYSE:CRL) shares over potential securities laws violations by...

Via SBWire

Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data

March 13, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.